A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria.
about
Guideline of Chronic Urticaria BeyondPosition statement for the use of omalizumab in the management of chronic spontaneous urticaria in Indian patientsChronic spontaneous urticaria: latest developments in aetiology, diagnosis and therapyProfile of omalizumab in the treatment of chronic spontaneous urticariaChronic urticaria in adults: state-of-the-art in the new millenniumNew era of biologic therapeutics in atopic dermatitisPersonalized Medicine in AllergyBiologics in asthma--the next step toward personalized treatmentClinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin.Increased cis-to-trans urocanic acid ratio in the skin of chronic spontaneous urticaria patients.Treatment of severe cold contact urticaria with omalizumab: case reportsSystematic review of treatments for chronic spontaneous urticaria with inadequate response to licensed first-line treatments.Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study.Omalizumab vs. placebo in the management of chronic idiopathic urticaria: a systematic review.Successful and Safe Treatment of Chronic Spontaneous Urticaria with Omalizumab in a Woman during Two Consecutive Pregnancies.Suppression of basophil FcɛRI activation by serum from active chronic idiopathic/spontaneous urticaria (CIU/CSU) subjectsStructural and Physical Basis for Anti-IgE Therapy.The role of autoimmune testing in chronic idiopathic urticaria.Omalizumab for Urticarial Vasculitis: Case Report and Review of the Literature.Research needs in allergy: an EAACI position paper, in collaboration with EFA.Diagnosis and treatment of urticaria and angioedema: a worldwide perspective.Retrospective analysis of the efficacy of omalizumab in chronic refractory urticariaTNF-Alpha Inhibitors for Chronic Urticaria: Experience in 20 PatientsBiologics in dermatology.Omalizumab for chronic urticaria in Latin America.IgE-Related Chronic Diseases and Anti-IgE-Based Treatments.Omalizumab in an allergology clinic: real life experience and future developments.Effectiveness of omalizumab in a patient with a life-threatening episode of bronchospasm and larynx angioedema after exposure to house dust.Biologic agents in the treatment of urticaria.Anti-IgE--emerging opportunities for Omalizumab.Urticaria and autoimmunity: where are we now?Treatment of refractory chronic urticaria: current and future therapeutic options.Pharmacotherapy of chronic spontaneous urticaria.The expanding role of therapeutic antibodies.Update and insights into treatment options for chronic spontaneous urticaria.The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update.Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria.Chronic urticaria: new management options.Omalizumab for the treatment of chronic urticaria.Omalizumab in patients with chronic spontaneous urticaria: a systematic review and GRADE assessment.
P2860
Q26743369-2DFB2A38-C7A2-4190-9D4B-9F3FB775B20FQ26767180-FFF95BA0-EBE9-4642-82EC-FED780CDCAE8Q26777088-79672BDC-76CC-4546-BBA7-80BF8430ABE5Q26783158-35A50D49-085B-49F3-9B4D-04A51E8FF035Q26849258-37431C49-666F-488A-A1C2-4B05C5500F3AQ27001941-5D3F0E15-364D-4AEC-93C6-3C8F0862E9D3Q28073074-DCBE7827-599D-4D77-96D4-DA9B563A2A81Q28085614-91FB9349-DEC0-4FBD-9904-4B0CC4909E5EQ33588223-9FEF1B93-BFB9-4B15-A031-E48B82B4C8A1Q33683786-CDDF5D5B-C25B-43EE-93FF-4BECE568AC3CQ34323869-37EA1DB7-6C8E-4ACA-AE2A-09FBB8E9C15DQ34454209-B3706CAB-3645-4E20-BEFE-5C1BBD3694ACQ34727734-CB984FC6-08DD-44D3-8209-057D1914E5EAQ34794295-6481BB95-D369-4AA3-B6DF-37EE04A53730Q35078702-1E4616C1-FD40-4397-A90A-E36E6F770FE1Q35478921-D8B9E8A9-9E2D-4145-B7EC-83AD303181AAQ35783662-9BEE368D-BEC6-485F-80CA-8AC9084B0A79Q35923496-26ED16AC-89B8-4A24-B20A-2EC6E6455D31Q36082959-5BFE1266-1D9B-42E8-B2BE-D08D1FF86BF4Q36517533-48D60D3E-1C3D-48C4-8122-BD9623F339C3Q36834774-4A59C424-6F30-4390-A372-46B1F65E95A9Q37121967-054E10ED-61A2-4820-A682-B4BEA10DCBF3Q37217942-D73D69CE-A2A1-4BA2-B66D-B5EBC43D7494Q37277398-197550C5-D121-4505-BB7F-4681ABB5F3A3Q37431777-1B708356-AD40-4EF7-B733-E7F165297DE5Q37554168-2166922F-4B1C-4AC6-A4FD-F00437C5BBB4Q37634329-0C4810A1-6B59-4970-8F1B-955284332546Q37634331-3B8F0B5F-D282-41BF-896E-B0CB17422856Q38022183-E60D9CD4-405D-4088-B77B-AA4DCD798F24Q38091754-87294A70-BDE3-4697-95CE-F378081D95CCQ38118905-EAE30847-499D-433B-B884-92E0D7BA160EQ38148494-620FEAE8-B34F-4229-8F8F-D4E356407B5AQ38160274-C3648223-F13F-47BE-BAE6-E270088E9CDAQ38182645-2FE82ACE-CE8D-4D69-941F-07405135ACF2Q38188032-61BDFBB0-A57D-41B2-806F-7637159E3C20Q38208428-B6CABEC6-15DA-4BB6-97DC-96DDDD0CC632Q38217720-3BA9520E-9247-47C2-8D47-74BACA9C2E50Q38266463-60D59C12-2107-4DAF-8C4F-1FC5FC3ED287Q38310407-3140196A-62FE-4E4D-8873-4DCA4F92DA89Q38428381-4B73BA14-9191-4932-B4FF-49B5052500E7
P2860
A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A randomized, placebo-controll ...... chronic idiopathic urticaria.
@ast
A randomized, placebo-controll ...... chronic idiopathic urticaria.
@en
A randomized, placebo-controll ...... chronic idiopathic urticaria.
@nl
type
label
A randomized, placebo-controll ...... chronic idiopathic urticaria.
@ast
A randomized, placebo-controll ...... chronic idiopathic urticaria.
@en
A randomized, placebo-controll ...... chronic idiopathic urticaria.
@nl
prefLabel
A randomized, placebo-controll ...... chronic idiopathic urticaria.
@ast
A randomized, placebo-controll ...... chronic idiopathic urticaria.
@en
A randomized, placebo-controll ...... chronic idiopathic urticaria.
@nl
P2093
P1476
A randomized, placebo-controll ...... chronic idiopathic urticaria.
@en
P2093
Allen Kaplan
Dennis A Wong
Edward Conner
Hsin-Ju Hsieh
Karin E Rosen
Marcus Maurer
Sarbjit Saini
Sheldon Spector
P304
P356
10.1016/J.JACI.2011.06.010
P407
P577
2011-07-18T00:00:00Z